Julian Wilkins is founder and vice president of PharmaConsult US, Inc. He has over 30 years of professional experience in architecture and containment solutions for the pharmaceutical industry. He has designed and managed the manufacture and qualification of containment systems for potent and aseptic compounds. In 1991 Julian co-founded a pharmaceutical isolator company in the UK and in 1999 founded PharmaConsult US, a consulting company that is dedicated to controlling product and people exposure in the pharmaceutical and biotech industries. He understands all aspects of Risk, Hazard and Exposure of People and Patients in the Pharmaceutical Industry, with particular emphasis on Exposure Control measures. Julian has assisted many clients in assessing their risk of cross contamination and operator exposure. From these risk assessments plan of actions are developed to assure that the high-risk areas are addressed while the low-risk areas are identified. Julian is also a founding member of the UK affiliation of ISPE, founding Chair of ISPE Containment COP and a core Team Member of the ISPE ISPE Baseline® Guide: Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP). He has given many papers worldwide at ISPE, PDA, Cleanrooms and Interphex.